alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel Development of High-Yield Technologies for Isolating Exfoliated Cells in Body Fluids.                    

*Date:*                         June 11, 2001.                    

*Time:*                         8 am to 4 pm.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, 6130 Executive Blvd., Conference Room C, Rockville, MD 20852.                    

*Contact Person:*                         Kenneth L. Bielat, PhD, Scientific Review Administrator, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Room 8043, Bethesda, MD 20892, (301) 496-7576.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: May 15, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 01-12915  Filed 5-22-01; 8:45 am]

BILLING CODE 4140-01-M
Exhibit 13.2
 Certification of the Principal Financial Officer of
Quebecor Media Inc.
pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
  (1)
    
    The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934, as amended; and(2)
    
    The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.
  /s/ Louis MorinName:
    Louis MorinTitle:
    Vice President and Chief Financial Officer The foregoing certification is being furnished solely pursuant to section 906 of the
Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United
States Code) and is not being filed as part of the Report or as a separate disclosure document.
exhibit10_1.htm






Exhibit 10.1







Summary of Compensation Agreement for Alex Incera







Title:                                       President, Gerber Coburn  (“GC”)


Vice President, Gerber Scientific, Inc. (“GSI”)


Base Salary:                           $190,000


Bonus Target:                         40%


Executive Severance:             8 months (Vice President Level)












Consequences of Material Change in GC Status







Notwithstanding anything in the Severance Policy for Senior Officers to the contrary (except as set forth in Clause (5) below), (1) if there is a significant change in the operating strategy of GC and Alex in not offered a comparable position to his current position within a GSI CT facility that (a) includes responsibility for a business unit with at the time not less than $30 million in annual sales; (b) reports to the CEO; and (c) includes a compensation package no less generous than his package as of this date, then Alex will receive the Severance Amount described below; or, (2) if GC is divested, and, upon, completion of the divestiture, Alex is offered a position with the acquirer that he chooses to accept, then he will receive the Sales Incentive described below, plus accelerated vesting of all shares of restricted stock and stock options then owned by him; (3) or, if GC is divested, and, upon completion of the divestiture, Alex is not offered a position with the acquirer, or he declines to accept a position with the acquirer in his sole discretion, but is offered a position with GSI, as described in the preceding Clause (1), then he will receive the Sales Incentive described below; or (4) if GC is divested, and, upon completion of the divestiture, Alex is not offered a position with the acquirer having comparable responsibilities and comparable total compensation to his current position and which does not require him to relocate; and he is not offered a position within GSI, as described in Clause 1 above, then he will receive the Severance Amount and Sales Incentive described below; or (5), if GC is divested, and upon completion of the divestiture, Alex is offered a comparable position with the acquirer having comparable responsibilities and comparable total compensation to his current position, which does not require him to relocate, and he declines to accept such position in his sole discretion, and he is not offered a position within GSI, as described in the preceding clause 1, then Alex will receive a severance amount that is standard for his position under the Severance Policy for Senior Officers (eight months) and Sales Incentive described below.













	
Severance Amount:

	
18 months at restored salary upon change in control or significant change of operating strategy of the GC business, including any earned bonus during this period; plus accelerated vesting of all unvested stock options and restricted shares; plus the continuation of insurance benefits provided for in the Severance Policy for Senior Officers.












Sale Incentive:                       1.0% of net sale price of GC
Marked-up changes to Contract Levies for ICE Futures U.S. RIN and RVO Futures and Option on Futures Contracts Fee

Screen ICE Clear EU Screen ICE Clear EU Block, EFS

Crude Oil and Refined Futures Products Commodity Code Futures Fee (per lot) Fee (per lot) Fee (per lot) Cash Settle (per lot)

Biofuel Outright - D3 RINs (OPIS) Balmo Future ROT 5.00 [10.00] 15.00 [10.00] 15.00 0.09

Biofuel Outright - D4 RINs (OPIS) Balmo Future ROD 5.00 [10.00] 15.00 [10.00] 15.00 0.09

Biofuel Outright - D5 RINs (OPIS) Balmo Future ROF 5.00 [10.00] 15.00 [10.00] 15.00 0.09

Biofuel Outright - D6 RINs (OPIS) Balmo Future ROS 5.00 [10.00] 15.00 [10.00] 15.00 0.09

Biofuel Outright - Argus RVO Current Year Future RVO [3.75] 5.00 [1.34] 15.00 [1.34] 15.00 0.09

Biofuel Outright - D3 RINs (OPIS) Current Year Future BFH [3.75] 5.00 [1.34] 15.00 [1.34] 15.00 0.09

Biofuel Outright - D4 RINS (OPIS) Current Year Future RIK [3.75] 5.00 [1.34] 15.00 [1.34] 15.00 0.09

Biofuel Outright - D5 RINs (OPIS) Current Year Future BFI [3.75] 5.00 [1.34] 15.00 [1.34] 15.00 0.09

Biofuel Outright - D6 RINs (OPIS) Future RIN [3.75] 5.00 [1.34] 15.00 [1.34] 15.00 0.09

Biofuel Outright - RVO (OPIS) Current Year Future RVB [3.75] 5.00 [1.34] 15.00 [1.34] 15.00 0.09

Biofuel Outright - Argus RVO Current Year Balmo Future BFF [3.75] 5.00 [1.34] 15.00 [1.34] 15.00 0.09

Biofuel Outright - Daily Argus RVO Current Year Future BFC [3.75] 5.00 [1.34] 15.00 [1.34] 15.00 0.09

Biofuel Outright - RVO (OPIS) Current Year Balmo Future BFE [3.75] 5.00 [1.34] 15.00 [1.34] 15.00 0.09

Biofuel Outright - Argus RVO Current Year Balmo Mini Future BFK [0.375] 0.500 [0.134] 1.500 [0.134] 1.500 0.009

Biofuel Outright - Daily Argus RVO Current Year Mini Future BFG [0.375] 0.500 [0.134] 1.500 [0.134] 1.500 0.009

Biofuel Outright - RVO (OPIS) Current Year Balmo Mini Future BFJ [0.375] 0.500 [0.134] 1.500 [0.134] 1.500 0.009

Biofuel Outright - RVO (OPIS) Current Year Mini Future BFA [0.375] 0.500 [0.134] 1.500 [0.134] 1.500 0.009

Biofuel Outright - Argus RVO Current Year Mini BFB [0.375] 0.500 [0.134] 1.500 [0.134] 1.500 0.009
Screen ICE Clear EU Screen ICE Clear EU Block, EFS

Crude Oil and Refined Options Products Commodity Code Futures Fee (per lot) Fee (per lot) Fee (per lot) Exercise (per Lot)

Biofuel Outright - D4 RINs (OPIS) Average Price Option RIK 5.00 [10.00] 15.00 [10.00] 15.00 0.30

Option on Biofuel Outright - D3 RINs (OPIS) Average Price Option BFH 5.00 [10.00] 15.00 [10.00] 15.00 0.30

Option on Biofuel Outright - D5 RINs (OPIS) Current Year Future BFI 5.00 [10.00] 15.00 [10.00] 15.00 0.30

Option on Biofuel Outright - D6 RINs (OPIS) Average Price Option RIN 5.00 [10.00] 15.00 [10.00] 15.00 0.30
# C_2017374EN.01004802.xml

| 6.11.2017 | EN | Official Journal of the European Union | C 374/48 |
| --- | --- | --- | --- |

6.11.2017

EN

Official Journal of the European Union

C 374/48

---

Action brought on 19 September 2017 — Top Cable v Commission and SRB

(Case T-630/17)

(2017/C 374/72)

Language of the case: Spanish

Parties

Parties

Applicant: Top Cable, SA (Rubí, Spain) (represented by: R. Vallina Hoset and A. Sellés Marco, lawyers)

Applicant:

Defendants: European Commission and Single Resolution Board

Defendants:

Form of order sought

Form of order sought

The applicant claims that the General Court should:

| — | Annul Decision SRB/EES/2017/08 of the Single Resolution Board of 7 June 2017 concerning the adoption of a resolution scheme in respect of Banco Popular Español, S.A.; |
| --- | --- |

—

Annul Decision SRB/EES/2017/08 of the Single Resolution Board of 7 June 2017 concerning the adoption of a resolution scheme in respect of Banco Popular Español, S.A.;

| — | Annul Commission Decision (EU) 2017/1246 of 7 June 2017 endorsing the resolution scheme of Banco Popular Español, S.A.; |
| --- | --- |

—

Annul Commission Decision (EU) 2017/1246 of 7 June 2017 endorsing the resolution scheme of Banco Popular Español, S.A.;

| — | Where appropriate, declare Articles 15, 18, 20, 21, 22 and/or 24 of Regulation No 806/2014 inapplicable, in accordance with Article 277 TFEU; |
| --- | --- |

—

Where appropriate, declare Articles 15, 18, 20, 21, 22 and/or 24 of Regulation No 806/2014 inapplicable, in accordance with Article 277 TFEU;

| — | Order SRB and the Commission to pay the costs. |
| --- | --- |

—

Order SRB and the Commission to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

The pleas in law and main arguments are similar to those put forward in Cases T-478/17, Mutualidad de la Abogacía and Hermandad Nacional de Arquitectos Superiores y Químicos v Single Resolution Board, T-481/17, Fundación Tatiana Pérez de Guzmán el Bueno and SFL v Single Resolution Board, T-482/17, Comercial Vascongada Recalde v Commission and Single Resolution Board, T-483/17, García Suárez and Others v Commission and Single Resolution Board, T-484/17, Fidesban and Others v Single Resolution Board, T-497/17, Sáchez del Valle and Calatrava Real State 2015 v Commission and Single Resolution Board, and T-498/17, Pablo Álvarez de Linera Granda v Commission and Single Resolution Board.

Mutualidad de la Abogacía and Hermandad Nacional de Arquitectos Superiores y Químicos

Single Resolution Board

Fundación Tatiana Pérez de Guzmán el Bueno and SFL

Single Resolution Board

Comercial Vascongada Recalde

Commission and Single Resolution Board

García Suárez and Others

Commission and Single Resolution Board

Fidesban and Others

Single Resolution Board

Sáchez del Valle and Calatrava Real State 2015

Commission and Single Resolution Board

Pablo Álvarez de Linera Granda

Commission and Single Resolution Board

---
COURT OF APPEALS FOR THE FIRST DISTRICT OF TEXAS AT HOUSTON Appellate case name: In re Sanni MEMORANDUM ORDER Appellate case number: 01 - 1:t-00144-CV Trial court case number: 2002-08930 Trial court: 309th District Court of Harris County Relator has filed a petition for a writ of mandamus. This court requests a response from the real party in xnterest. SeeTEX. R. App. P. 52.4. The response, if any, is due March 7, 2013. It 1s SO ORDERED. Judge’s signature:/s/Rebeca Huddle

[] Acting individually [] Acting for the Court 

### Date: February 20, 2013
Exhibit 32.1





CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER


PURSUANT TO 18 U.S.C. SECTION 1350


AS ADOPTED PURSUANT TO





SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





I, Harvey Judkowitz, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Photovoltaic Solar Cells, Inc. on Form 10-Q, for the quarter ended May 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Photovoltaic Solar Cells, Inc.




Dated: July 20, 2011
/s/ Harvey JudkowitzHarvey Judkowitz, Chief Executive Officer
Exhibit 21.1



VillageEDOCS List of Subsidiaries







|   | Name of Subsidiary              | State or Jurisdiction of Incorporation | DBAs               
|-- | ------------------------------- | -------------------------------------- | -------------------
|   |                                 |                                        |                    
|1. | Tailored Business Systems, Inc. | Georgia                                | None.              
|2. | MessageVision, Inc.             | California                             | None.              
|3. | Phoenix Forms, Inc.             | Georgia                                | Resolutions        
|4. | GoSolutions, Inc.               | Florida                                | GoSolo Technologies



---
# C_2017347EN.01003602.xml

| 16.10.2017 | EN | Official Journal of the European Union | C 347/36 |
| --- | --- | --- | --- |

16.10.2017

EN

Official Journal of the European Union

C 347/36

---

Action brought on 4 August 2017 — Ruiz Sacristán and Arias Mosquera v Commission and SRB

(Case T-503/17)

(2017/C 347/46)

Language of the case: Spanish

Parties

Parties

Applicants: Jaime Ruiz Sacristán (Cuauhtémoc, Mexico), José María Arias Mosquera (Madrid, Spain) (represented by: B. Gutiérrez de la Roza Pérez, P. Rubio Escobar, R. Ruiz de la Torre Esporrín and B. Fernández García, lawyers)

Applicants:

Defendants: European Commission and Single Resolution Board

Defendants:

Form of order sought

Form of order sought

The applicants claim that the Court should annul the following measures:

| — | Decision SRB/EES/2017/08 of the Single Resolution Board taken at its executive session of 7 June 2017 adopting the resolution scheme regarding the institution Banco Popular Español S.A.. |
| --- | --- |

—

Decision SRB/EES/2017/08 of the Single Resolution Board taken at its executive session of 7 June 2017 adopting the resolution scheme regarding the institution Banco Popular Español S.A..

| — | Commission Decision (EU) 2017/1246 of 7 June 2017 endorsing the resolution scheme for Banco Popular Español, S.A. |
| --- | --- |

—

Commission Decision (EU) 2017/1246 of 7 June 2017 endorsing the resolution scheme for Banco Popular Español, S.A.

Pleas in law and main arguments

Pleas in law and main arguments

The pleas in law and main arguments are similar to those put forward in Cases T-478/17, Mutualidad de la Abogacía and Hermandad Nacional de Arquitectos Superiores y Químicos v Single Resolution Board, T-481/17, Fundación Tatiana Pérez de Guzmán el Bueno and SFL v Single Resolution Board, T-482/17, Comercial Vascongada Recalde v Commission and Single Resolution Board, T-483/17, García Suárez and Others v Commission and Single Resolution Board, T-484/17, Fidesban and Others v Single Resolution Board, T-497/17, Sáchez del Valle and Calatrava Real State 2015 v Commission and Single Resolution Board, y T-498/17, Pablo Álvarez de Linera Granda v Commission and Single Resolution Board.

Mutualidad de la Abogacía and Hermandad Nacional de Arquitectos Superiores y Químicos

Single Resolution Board

Fundación Tatiana Pérez de Guzmán el Bueno

SFL

Single Resolution Board

Comercial Vascongada Recalde

Commission and Single Resolution Board

García Suárez and Others

Commission and Single Resolution Board

Fidesban and Others

Single Resolution Board

Sáchez del Valle and Calatrava Real State 2015

Commission and Single Resolution Board

Pablo Álvarez de Linera Granda

Commission and Single Resolution Board

---
Exhibit 10.19.1  [SYNTA LETTERHEAD]  AMENDMENT TO CONSULTING AGREEMENT  THIS
AMENDMENT(Amendment) is made as of March 23, 2007
(the Effective Date) by and between Synta Pharmaceuticals
Corp., a Delaware corporation with a principal place of business at
45 Hartwell Avenue, Lexington, MA 02421 (Synta) and Lan Bo Chen,
Ph.D. (Consultant) with a principal place of business at 184 East
Emerson Rd., Lexington, MA 02420.  Synta
entered into a Consulting Agreement with Consultant, dated as of April 18,
2005 (Agreement).  The parties hereby
agree to amend the Agreement as follows:  ·The Consulting Fee set forth in Section 3(a) shall
be revised to replace the fee of Twenty-Five Thousand Dollars per month with a
fee of Ten Thousand Dollars ($10,000.00) per month.  This new fee shall be effective beginning
with the payment for Consulting Services rendered during the month of March,
2007.  In
all other respects, the terms of the Agreement shall remain unmodified and in
full force and effect.  All capitalized terms
used in this Amendment shall have the same meaning as set forth in the
Agreement.  The
parties have indicated their acceptance of the terms of this Amendment by the
signatures set forth below.  Each
individual signing on behalf of a corporate entity hereby personally represents
and warrants his or her legal authority to legally bind that entity.  SYNTA
  PHARMACEUTICALS CORP.
  LAN
  BO CHEN, PH.D.By
  /s/
  SAFI R. BAHCALL
  
  /s/
  LAN BO CHENSafi
  R. Bahcall, Ph.D.President
  and Chief Executive Officer
<PAGE>



                                                                    EXHIBIT 32.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of Atlas America Public #10 Ltd. (the
"Partnership") on Form 10-KSB for the year ended December 31, 2003 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Freddie M. Kotek, Chief Executive Officer of the Managing General Partner,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

    (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934, and

    (2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Partnership.


                                                 /s/ Freddie M. Kotek
                                                 ------------------------------
                                                 Freddie M. Kotek
                                                 Chief Executive Officer of the
                                                 Managing General Partner
                                                 March 29, 2004
|   | /s/ Kim Bradford                                     |   |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|

|   | Kim Bradford |
|--------|--------------|

|   | Chief Financial Officer |
|--------|-------------------------|

|   | (Principal Financial Officer) |
|--------|-------------------------------|

|   |
|--------|

|   | /s/ Kim Bradford                                   |   |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|

|   | Kim Bradford, |
|--------|---------------|

|   | President and Chief Executive Officer, |
|--------|----------------------------------------|

|   | (Principal Executive Officer) |
|--------|-------------------------------|

----
June 28, 2006

Ms. Eileen A. Donovan

Acting Secretary

Commodity Futures Trading Commission
Three Lafayette Center

1155 21" Street, N.W.

Washington, D.C. 20581

Reference File # 2692.01
Rule Certification
Dear Ms. Donovan:

Pursuant to Commission Regulation 40.6(a), the Chicago Board of Trade (CBOT®) hereby
submits the following revised option expiration schedule:

- Change the last trading day/expiration for January 2007 CBOT Soybean Board
Crush Spread options from Friday, December 22 to Thursday, December 21, 2006.

There is no open interest in the referenced contract.

This revision to the option expiration schedule is designed to minimize holiday-related
scheduling issues in connection with the 2006 Christmas holiday. This change is consistent with
a change previously established for all other CBOT January 2007 agricultural options.

The CBOT intends to implement this change one day after the Commission’s receipt of this
filing.

There were no opposing views concerning this change.

The CBOT certifies that this change conforms with the Commodity Exchange Act and the rules
thereunder.

Sincerely,

Paul J. Draths
Vice President and Secretary
##### 



Exhibit 8.1
 Main Subsidiaries of Quebecor Media Inc.
 Jurisdiction of Incorporation orName of Subsidiary
    
    Organization
    
    Equity Interest/Voting InterestVideotron Ltd / Vidéotron ltée
    
    Québec
    
    100% / 100%CF Câble TV inc. / CF Cable TV Inc.
    
    Canada
    
    100% / 100%Le SuperClub Vidéotron ltée
    
    Québec
    
    100% / 100%Sun Media Corporation /Corporation 
Sun Media
    
    British Columbia
    
    100% / 100%Bowes Publishers Limited
    
    British Columbia
    
    100% / 100%Sun Media (Toronto) Corporation
    
    British Columbia
    
    100% / 100%Osprey Media Publishing Inc.
    
    Canada
    
    100% / 100%Quebecor Pages Media Inc.
    
    Canada
    
    100% / 100%4307046 Canada Inc.
    
    Canada
    
    100% / 100%Groupe TVA Inc. / TVA Group Inc.
    
    Québec
    
    45.2% / 99.9%TVA Publications Inc.
    
    Canada
    
    100% / 100%Groupe Archambault inc. /Archambault
Group Inc.
    
    Canada
    
    100% / 100%Quebecor Media Book Group Inc.
    
    Canada
    
    100% / 100%Les Éditions CEC inc.
    
    Québec
    
    100% / 100%Groupe Sogides Inc.
    
    Canada
    
    100% / 100%Canoë inc. / Canoe Inc.
    
    Québec
    
    92.5% / 99.9%Nurun Inc.
    
    Canada
    
    100% / 100%
Case 1:07-cr-00566-GBD Document 34 Filed 05/02/2008 Page 1 of 1